We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. Its reportable segments: (1) the development a... Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. Its reportable segments: (1) the development and commercialization of novel clean-surfaced nanotechnology therapeutics (Drugs, and (2) the development and commercialization of dietary supplements (Supplements). Show more
LOS ANGELES, Aug. 08, 2024 (GLOBE NEWSWIRE) -- via IBN β IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.05 | 1.02249488753 | 4.89 | 4.9905 | 4.5 | 64228 | 4.73573218 | CS |
4 | -0.16 | -3.13725490196 | 5.1 | 6.2899 | 4.5 | 75336 | 5.23135827 | CS |
12 | -1.44 | -22.5705329154 | 6.38 | 6.5 | 3.85 | 85192 | 4.76608317 | CS |
26 | 0.4299 | 9.53193942485 | 4.5101 | 6.96 | 3.8181 | 106773 | 5.28011484 | CS |
52 | -4.528 | -47.8242501056 | 9.468 | 11 | 3.8181 | 419616 | 7.34100272 | CS |
156 | -45.26 | -90.1593625498 | 50.2 | 102.6 | 3.8181 | 535140 | 29.13771593 | CS |
260 | -186.06 | -97.4136125654 | 191 | 356.4 | 3.8181 | 463893 | 53.93697126 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions